Iridex (IRIX) Notes Payables (2011 - 2024)

Iridex (IRIX) posted Notes Payables of $1.7 million for Q4 2024, up 31.96% on a QoQ basis from $1.3 million in Q3 2024.

Analysis

Iridex (IRIX) Notes Payables (2011 - 2024) Analysis & Trends

Iridex has reported Notes Payables for 7 years, with the latest figure at $1.7 million in Q4 2024.

On a quarterly basis, Notes Payables changed N/A year-over-year to $1.7 million in Q4 2024; TTM through Dec 2024 was $1.7 million, a N/A change from a year earlier, with the FY2024 full-year figure at $1.7 million, changed N/A from the prior year.
Notes Payables was $1.7 million for Q4 2024 at Iridex, up from $1.3 million in the prior quarter.
The five-year high for Notes Payables was $1.7 million in Q4 2024, with the low at $1.3 million in Q3 2024.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	183.04 Bn	177.44 Bn	7.27 Bn
2	Intuitive Surgical	125.02 Bn	119.81 Bn	1.96 Bn
3	Medtronic	117.84 Bn	109.02 Bn	6.34 Bn
4	Stryker	105.50 Bn	102.02 Bn	4.50 Bn
5	Boston Scientific	66.27 Bn	65.73 Bn	3.85 Bn
6	Edwards Lifesciences	49.60 Bn	45.35 Bn	1.35 Bn
7	Alcon	33.70 Bn	32.24 Bn	1.68 Bn
8	Dexcom	32.06 Bn	30.11 Bn	830.00 Mn
9	Steris	21.02 Bn	20.54 Bn	684.20 Mn
10	Iridex	11.85 Mn	7.17 Mn	4.30 Mn

Historic Data

Download Data